Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 76
Summary
- Conditions
- Dry Eye Syndromes
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01568593
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon